Liz O’Donovan

860 total citations
16 papers, 690 citations indexed

About

Liz O’Donovan is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Liz O’Donovan has authored 16 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Toxicology. Recurrent topics in Liz O’Donovan's work include Muscle Physiology and Disorders (5 papers), RNA Interference and Gene Delivery (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Liz O’Donovan is often cited by papers focused on Muscle Physiology and Disorders (5 papers), RNA Interference and Gene Delivery (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Liz O’Donovan collaborates with scholars based in United Kingdom, Sweden and Ireland. Liz O’Donovan's co-authors include Michael J. Gait, Matthew J. A. Wood, Caroline Godfrey, Corinne Betts, Prisca Boisguérin, Bernard Lebleu, Sébastien Deshayes, Peter Järver, Michael P. Carty and Fawaz Aldabbagh and has published in prestigious journals such as Nano Letters, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Liz O’Donovan

16 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liz O’Donovan United Kingdom 12 580 99 88 69 40 16 690
Thibault Coursindel France 10 639 1.1× 51 0.5× 91 1.0× 88 1.3× 39 1.0× 16 691
Luciano H. Apponi United States 18 979 1.7× 39 0.4× 61 0.7× 104 1.5× 16 0.4× 23 1.1k
Sonali P. Jog United States 11 607 1.0× 40 0.4× 36 0.4× 37 0.5× 10 0.3× 12 724
Anastasia A. Malakhova Russia 11 263 0.5× 41 0.4× 43 0.5× 34 0.5× 20 0.5× 48 355
Wenli Zhang China 13 509 0.9× 66 0.7× 64 0.7× 17 0.2× 5 0.1× 27 610
Andrew Metcalfe Canada 9 293 0.5× 35 0.4× 29 0.3× 39 0.6× 82 2.0× 14 472
Christina B. Cooley United States 9 425 0.7× 95 1.0× 54 0.6× 8 0.1× 33 0.8× 12 689
Swathi Krishnan United States 11 340 0.6× 33 0.3× 37 0.4× 10 0.1× 20 0.5× 14 481
Kazutaka Nishina Japan 12 698 1.2× 31 0.3× 89 1.0× 28 0.4× 89 2.2× 23 882
Reinhard Zeitler Germany 8 650 1.1× 335 3.4× 28 0.3× 27 0.4× 18 0.5× 11 720

Countries citing papers authored by Liz O’Donovan

Since Specialization
Citations

This map shows the geographic impact of Liz O’Donovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liz O’Donovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liz O’Donovan more than expected).

Fields of papers citing papers by Liz O’Donovan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liz O’Donovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liz O’Donovan. The network helps show where Liz O’Donovan may publish in the future.

Co-authorship network of co-authors of Liz O’Donovan

This figure shows the co-authorship network connecting the top 25 collaborators of Liz O’Donovan. A scholar is included among the top collaborators of Liz O’Donovan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liz O’Donovan. Liz O’Donovan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gupta, Dhanu, Janne J. Turunen, Liz O’Donovan, et al.. (2023). Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation. Cells. 12(18). 2285–2285. 4 indexed citations
2.
Blain, A., Elizabeth Greally, Graham McClorey, et al.. (2018). Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy. PLoS ONE. 13(6). e0198897–e0198897. 18 indexed citations
3.
Coenen-Stass, Anna, Helena Sork, Sole Gatto, et al.. (2018). Comprehensive RNA-Sequencing Analysis in Serum and Muscle Reveals Novel Small RNA Signatures with Biomarker Potential for DMD. Molecular Therapy — Nucleic Acids. 13. 1–15. 38 indexed citations
4.
Betts, Corinne, Graham McClorey, Suzan M. Hammond, et al.. (2018). Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment. Human Molecular Genetics. 28(3). 396–406. 9 indexed citations
5.
Boisguérin, Prisca, Sébastien Deshayes, Michael J. Gait, et al.. (2015). Delivery of therapeutic oligonucleotides with cell penetrating peptides. Advanced Drug Delivery Reviews. 87. 52–67. 204 indexed citations
6.
Godfrey, Caroline, Graham McClorey, Kim E. Wells, et al.. (2015). How much dystrophin is enough: the physiological consequences of different levels of dystrophin in themdxmouse. Human Molecular Genetics. 24(15). 4225–4237. 106 indexed citations
8.
Ezzat, Kariem, Yoshitsugu Aoki, Taeyoung Koo, et al.. (2015). Self-Assembly into Nanoparticles Is Essential for Receptor Mediated Uptake of Therapeutic Antisense Oligonucleotides. Nano Letters. 15(7). 4364–4373. 82 indexed citations
9.
O’Donovan, Liz, Itaru Okamoto, Andrey Arzumanov, et al.. (2014). Parallel Synthesis of Cell-Penetrating Peptide Conjugates of PMO Toward Exon Skipping Enhancement in Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. 25(1). 1–10. 15 indexed citations
10.
O’Donovan, Liz & Paul De Bank. (2014). A hydrazide-anchored dendron scaffold for chemoselective ligation strategies. Organic & Biomolecular Chemistry. 12(37). 7290–7296. 5 indexed citations
11.
Järver, Peter, Liz O’Donovan, & Michael J. Gait. (2013). A Chemical View of Oligonucleotides for Exon Skipping and Related Drug Applications. Nucleic Acid Therapeutics. 24(1). 37–47. 69 indexed citations
12.
O’Donovan, Liz & Paul De Bank. (2012). A photocleavable linker for the chemoselective functionalization of biomaterials. Journal of Materials Chemistry. 22(41). 21878–21878. 8 indexed citations
13.
Bonham, Sarah, Liz O’Donovan, Michael P. Carty, & Fawaz Aldabbagh. (2011). First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines. Organic & Biomolecular Chemistry. 9(19). 6700–6700. 16 indexed citations
14.
O’Donovan, Liz, et al.. (2010). The influence of the aziridinyl substituent of benzimidazoles and benzimidazolequinones on toxicity towards normal and Fanconi anaemia cells. European Journal of Medicinal Chemistry. 45(5). 1873–1879. 30 indexed citations
15.
O’Donovan, Liz, Michael P. Carty, & Fawaz Aldabbagh. (2008). First synthesis of N-[(aziridin-2-yl)methyl]benzimidazolequinone and analysis of toxicity towards normal and Fanconi anemia cells. Chemical Communications. 5592–5592. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026